Abbott Restarts Production of Baby Formula at Plant in Sturgis, Michigan
On Saturday, baby formula production restarted at the Abbott plant in Sturgis Michigan. Abbott will begin with production of ‘EleCare’ an amino acid-based hypoallergenic product for babies who can’t tolerate other formulas, as well as other specialty formulas with it’s first batches expected to be available to consumers around June 20th. Similac and other products that are made at the plant will take longer to become available. The plant has been shut down for months following an FDA inspection that found bacteria which can be deadly to infants leading to Similac, Alimentum and EleCare formulas made at the plant were recalled. Last month, a federal judge signed off on an agreement between the FDA and Abbott that laid out steps the company took to restart production.